European Parliament nicotine event access row raises Article 5.3 questions
November 17, 2026 by clearingtheair.eu
European Parliament nicotine event access row raises Article 5.3 questions
A European Parliament event examining the science of emerging nicotine products has faced criticism after several tobacco harm reduction advocates reported being denied access.
Organisers cited WHO tobacco treaty provisions restricting industry influence, while critics questioned the exclusion of independent advocates and the involvement of a pharmaceutical company producing nicotine replacement therapies.
The controversy raises broader questions about transparency, conflicts of interest and scientific debate in EU tobacco policy. Evidence-based regulation requires open scrutiny of competing perspectives, particularly on the relative risks of nicotine products and their potential role in reducing smoking-related harm.
19.30% of the adult population are current smokers. There are approximately 13.9 million current smokers in Germany 22.10% of men are current smokers but only 16.50% of women.
SOURCE: GSTHR